A Study of Belimumab in Subjects With Systemic Lupus Erythematosus

Clinical trial NCT00410384 · COMPLETED

Trial details

NCT number: NCT00410384
Sponsor: Human Genome Sciences Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2006-12-01
Primary completion: 2009-09-01
Enrollment: 819

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.